0001127602-18-035752.txt : 20181210 0001127602-18-035752.hdr.sgml : 20181210 20181210204631 ACCESSION NUMBER: 0001127602-18-035752 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181206 FILED AS OF DATE: 20181210 DATE AS OF CHANGE: 20181210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacks Tyler CENTRAL INDEX KEY: 0001464237 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 181227607 MAIL ADDRESS: STREET 1: 77 MASSACHUSETTS AVENUE E17-517 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-12-06 0000318154 AMGEN INC AMGN 0001464237 Jacks Tyler ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 Common Stock 2018-12-06 4 M 0 20000 82.60 A 28979 D Common Stock 2018-12-06 4 S 0 20000 195.4116 D 8979 D Nqso (Right to Buy) 82.60 2018-12-06 4 M 0 20000 0 D 2013-07-31 2022-07-31 Common Stock 20000 0 D The price reported is an average price. the prices ranged from $195.28 to $195.83 per share for this cashless exercise of 20,000 stock options expiring July 31, 2022. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. These shares include 467 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. /s/ Tyler Jacks 2018-12-06